NCT04084873

Brief Summary

The study aims is to test the efficacy of an emotional regulation procedure for fibromyalgia patients using Information and Communications Technologies (ICTs). This procedure is based in a task that implies exposition to emotional words. The principal hypothesis is that exposition will improve the clinical symptomatology because the procedure restore an adequate emotional regulation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 10, 2019

Completed
27 days until next milestone

Study Start

First participant enrolled

October 7, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

November 6, 2020

Status Verified

November 1, 2020

Enrollment Period

1.6 years

First QC Date

September 4, 2019

Last Update Submit

November 5, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Combined Index of Severity in Fibromyalgia (ICAF). Change is being assessed

    The Combined Index of Severity in Fibromyalgia (ICAF) is a questionnaire that allows the classification of patients by severity in clinical practice. This analysis is a self-report questionnaire of 59 items constructed with the most common clinical manifestations of FM (Vallejo, Rivera, \& Esteve-Vives, 2010). The ICAF questionnaire offers total scores, where higher scores indicate a more severe disease. This questionnaire also provides four factors: emotional, physical (pain, fatigue, sleep quality and functional capacity), active coping, and passive coping. Similar to the total score, higher scores on each factor indicate greater severity, with the exception of the active coping factor, where higher scores indicate a better way to cope with the disease.

    Through study completion, an average of 1 year

  • Fibromyalgia Impact Questionnaire (FIQ). Change is being assessed

    The Fibromyalgia Impact Questionnaire (FIQ) (Burckhardt, Clark, \& Bennett, 1991; Rivera \& González, 2004) is a self-report questionnaire designed to evaluate the impact of the FM on the life of the patient. This 10-item questionnaire is widely used and covers the principal areas of interest, including physical functioning, pain, sleep, mental health, and fatigue. The score ranges from 0 to 100, where higher scores indicate a more severe impact of the disease.

    Through study completion, an average of 1 year

Secondary Outcomes (7)

  • EuroQol-5D-5L

    Through treatment completion, an average of 6 weeks

  • Credibility and Expectancy Questionnaire (CEQ)

    Through treatment completion, an average of 6 weeks

  • Client Satisfaction Questionnaire

    Through treatment completion, an average of 6 weeks

  • Pain Catastrophizing Scale (PCS)

    Through study completion, an average of 1 year

  • Acceptance and Action Questionnaire - II

    Through study completion, an average of 1 year

  • +2 more secondary outcomes

Study Arms (3)

Experimental PBrE

EXPERIMENTAL

Participants are exposed to several words of emotional contents (positive, and negative). The differences between these words will allow the regulation and counter regulation of emotional processes (Schwager y Rothermund, 2013). The words are related to clinical and personal characteristics of the patients and they will promote an emotional identification that improve the emotional regulation (Kashdan, Barret y McKnight, 2015).

Behavioral: PBrE

Control PBrE

PLACEBO COMPARATOR

Participants are exposed to several neutral words. These words do not have any emotional content and there are no reasons to think that they have any effect over the emotional regulation.

Behavioral: PBrE-Control

Control

OTHER

Participants do not receive the intervention.

Behavioral: Control

Interventions

PBrEBEHAVIORAL

PbRE is a word reading task implementing through an App developed for smartphones. The patient will choose emotional positive and negative words related to personal and clinical characteristics.

Experimental PBrE
PBrE-ControlBEHAVIORAL

Participants are exposed to several neutral words. These words do not have any emotional content and there are no reasons to think that they have any effect over the emotional regulation.

Control PBrE
ControlBEHAVIORAL

Participants do not receive the intervention.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Met the American College of Rheumatology (ACR) 2010 research classification criteria for FM (Wolfe et al., 2010, 2011); as confirmed by a rheumatologist
  • A minimum of 18 years of age
  • Showed adequate reading comprehension
  • Were able to use a smartphone
  • Were able to sign an informed consent form.

You may not qualify if:

  • Had any mental disorder treated by a psychiatrist
  • Were scheduled for surgery in the next 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Miguel A. Vallejo

Madrid, 28040, Spain

Location

Related Publications (6)

  • Arntz A, Hawke LD, Bamelis L, Spinhoven P, Molendijk ML. Changes in natural language use as an indicator of psychotherapeutic change in personality disorders. Behav Res Ther. 2012 Mar;50(3):191-202. doi: 10.1016/j.brat.2011.12.007. Epub 2012 Jan 4.

    PMID: 22317755BACKGROUND
  • Bennett MP, Meulders A, Baeyens F, Vlaeyen JW. Words putting pain in motion: the generalization of pain-related fear within an artificial stimulus category. Front Psychol. 2015 Apr 30;6:520. doi: 10.3389/fpsyg.2015.00520. eCollection 2015.

    PMID: 25983704BACKGROUND
  • Duschek S, Werner NS, Limbert N, Winkelmann A, Montoya P. Attentional bias toward negative information in patients with fibromyalgia syndrome. Pain Med. 2014 Apr;15(4):603-12. doi: 10.1111/pme.12360. Epub 2014 Jan 21.

    PMID: 24447855BACKGROUND
  • Mercado F, Gonzalez JL, Barjola P, Fernandez-Sanchez M, Lopez-Lopez A, Alonso M, Gomez-Esquer F. Brain correlates of cognitive inhibition in fibromyalgia: emotional intrusion of symptom-related words. Int J Psychophysiol. 2013 May;88(2):182-92. doi: 10.1016/j.ijpsycho.2013.03.017. Epub 2013 Apr 2.

    PMID: 23557844BACKGROUND
  • Montoya P, Sitges C, Garcia-Herrera M, Izquierdo R, Truyols M, Blay N, Collado D. Abnormal affective modulation of somatosensory brain processing among patients with fibromyalgia. Psychosom Med. 2005 Nov-Dec;67(6):957-63. doi: 10.1097/01.psy.0000188401.55394.18.

    PMID: 16314601BACKGROUND
  • Schwager S, Rothermund K. Counter-regulation triggered by emotions: positive/negative affective states elicit opposite valence biases in affective processing. Cogn Emot. 2013;27(5):839-55. doi: 10.1080/02699931.2012.750599. Epub 2012 Dec 14.

    PMID: 23237331BACKGROUND

MeSH Terms

Conditions

FibromyalgiaChronic Pain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2019

First Posted

September 10, 2019

Study Start

October 7, 2019

Primary Completion

May 1, 2021

Study Completion

October 1, 2021

Last Updated

November 6, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations